chr11-128968914-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001378024.1(ARHGAP32):c.6299C>T(p.Ala2100Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000394 in 1,522,564 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. A2100A) has been classified as Likely benign.
Frequency
Consequence
NM_001378024.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ARHGAP32 | NM_001378024.1 | c.6299C>T | p.Ala2100Val | missense_variant | 23/23 | ENST00000682385.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ARHGAP32 | ENST00000682385.1 | c.6299C>T | p.Ala2100Val | missense_variant | 23/23 | NM_001378024.1 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000525 AC: 1AN: 190482Hom.: 0 AF XY: 0.00000995 AC XY: 1AN XY: 100470
GnomAD4 exome AF: 0.00000219 AC: 3AN: 1370360Hom.: 0 Cov.: 30 AF XY: 0.00000149 AC XY: 1AN XY: 669620
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 13, 2024 | The c.6257C>T (p.A2086V) alteration is located in exon 22 (coding exon 22) of the ARHGAP32 gene. This alteration results from a C to T substitution at nucleotide position 6257, causing the alanine (A) at amino acid position 2086 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at